Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
TSE:4554
Price:
1 370
JPY
1.11%
Market Closed
Market Cap:
33.9B
JPY
Fuji Pharma Co Ltd
Other
|
Fuji Pharma Co Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fuji Pharma Co Ltd
TSE:4554
|
Other
¥11m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other
-¥125.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-19%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other
-¥2.5B
|
CAGR 3-Years
-278%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
5%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other
¥233m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Other
-¥23.8B
|
CAGR 3-Years
-111%
|
CAGR 5-Years
-95%
|
CAGR 10-Years
-41%
|
|
Fuji Pharma Co Ltd
Glance View
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
Intrinsic Value
2 023.31
JPY
Undervaluation 32%
See Also
What is Fuji Pharma Co Ltd's Other?
Other
11m
JPY
11m
JPY
Based on the financial report for Dec 31, 2024, Fuji Pharma Co Ltd's Other amounts to 11m JPY.
You don't have any saved screeners yet